Scott M. Coiante

This profile gathers the share dealings of Scott M. Coiante across 3 companies, led by Agile Therapeutics Inc, Aprea Therapeutics, Inc. and Lexicon Pharmaceuticals, Inc. We count 13 filings; the first trade dates from 25 January 2018 and the latest from 28 February 2026.

On the market, this insider has only ever bought: 1 purchase, €34k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 7 share grants and 4 option exercises.

The newest entry dates from 3 March 2026: an option exercise, in Lexicon Pharmaceuticals, Inc. The last insider purchase was made public on 7 October 2019, 2,571 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.